In this video, Millie Long, MD, MPH, from the University of North Carolina at Chapel Hill, discusses best practices for the treatment of severe Crohn disease and updates from the American College of...
Russell Cohen, MD, reviews his presentation from the virtual AIBD regional meeting July 25 on defining the target to treat in inflammatory bowel disease.
He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on...
